Risk Factors for Cytomegalovirus Disease in Solid Organ Transplantation

Completed

Conditions studied: Transplantation, Infection, Cytomegalovirus Infections

In brief

This study will investigate the clinical variables that may be used to predict who among the solid organ transplant recipients will develop cytomegalovirus (CMV) disease after completing antiviral prophylaxis.

Key facts

Study ID

NCT00170170

Run by

Mayo Clinic

People needed

500

Starts

2004-11-01

Expected to finish

2007-06-01

Last updated by the study team

2010-02-02

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Recipients of liver, kidney, pancreas, heart or lung transplantation

Where it is running

• Mayo Clinic — Rochester, Minnesota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.